Clinical trial
Idebenone to Treat Friedreich's Ataxia
NCT00229632 · National Institute of Neurological Disorders and Stroke (NINDS), NIH · Completed
Key facts
| NCT number | NCT00229632 |
|---|---|
| Title | Idebenone to Treat Friedreich's Ataxia |
| Official title | A Six Month Double-Blind, Placebo-Controlled Phase 2 Clinical Trial to Determine the Safety and Efficacy of Idebenone Administered to Patients With Friedreich's Ataxia |
| Lead sponsor | National Institute of Neurological Disorders and Stroke (NINDS), NIH |
| Status | Completed |
| Phase | Phase 2 |
| Study type | Interventional |
| Conditions | Friedreich Ataxia |
| Intervention type | Drug |
| Interventions | Idebenone |
| Enrollment | 51 |
| Start date | Sep 27, 2005 |
| Primary completion | Dec 17, 2007 |
| Completion | Dec 17, 2007 |
| First posted | Sep 29, 2005 |
| Last update posted | Mar 18, 2019 |
| Countries | United States |
At a glance
- 1–9 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: